ZA932526B - Method of treatment of hiv-seropositive individuals with dietary whey proteins - Google Patents
Method of treatment of hiv-seropositive individuals with dietary whey proteinsInfo
- Publication number
- ZA932526B ZA932526B ZA932526A ZA932526A ZA932526B ZA 932526 B ZA932526 B ZA 932526B ZA 932526 A ZA932526 A ZA 932526A ZA 932526 A ZA932526 A ZA 932526A ZA 932526 B ZA932526 B ZA 932526B
- Authority
- ZA
- South Africa
- Prior art keywords
- hiv
- treatment
- seropositive individuals
- whey proteins
- cells
- Prior art date
Links
- 108010046377 Whey Proteins Proteins 0.000 title abstract 2
- 235000021119 whey protein Nutrition 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 4
- 229960003180 glutathione Drugs 0.000 abstract 2
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 2
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 210000005087 mononuclear cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/866,756 US5456924A (en) | 1988-12-23 | 1992-04-10 | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA932526B true ZA932526B (en) | 1994-03-09 |
Family
ID=25348339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA932526A ZA932526B (en) | 1992-04-10 | 1993-04-08 | Method of treatment of hiv-seropositive individuals with dietary whey proteins |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5456924A (ja) |
| EP (1) | EP0634934B1 (ja) |
| JP (1) | JP2738592B2 (ja) |
| KR (1) | KR100297959B1 (ja) |
| CN (1) | CN1070371C (ja) |
| AT (1) | ATE187335T1 (ja) |
| AU (1) | AU687731B2 (ja) |
| CA (1) | CA2090186C (ja) |
| CZ (1) | CZ283386B6 (ja) |
| DE (1) | DE69327236T2 (ja) |
| DK (1) | DK0634934T3 (ja) |
| ES (1) | ES2143503T3 (ja) |
| IL (1) | IL105339A (ja) |
| MX (1) | MX9302057A (ja) |
| NO (1) | NO317795B1 (ja) |
| NZ (1) | NZ251271A (ja) |
| TW (1) | TW384223B (ja) |
| WO (1) | WO1993020831A1 (ja) |
| ZA (1) | ZA932526B (ja) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6241983B1 (en) | 1994-10-28 | 2001-06-05 | Metagenics, Inc. | Bacteria-and fiber-containing composition for human gastrointestinal health |
| US5531989A (en) | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
| US5985275A (en) * | 1995-04-12 | 1999-11-16 | New York Blood Center | β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection |
| CA2165937A1 (en) * | 1995-05-09 | 1996-11-10 | Immunotec Research Corporation Ltd. | Process for producing an undenatured whey protein concentrate |
| CA2247860C (en) * | 1996-03-06 | 2002-03-19 | I. Belloch Corporation | Method for treating liquid materials |
| WO1997034619A1 (en) * | 1996-03-20 | 1997-09-25 | New York Blood Center | Methods of treating herpes or chlamydia |
| US5952009A (en) * | 1996-03-20 | 1999-09-14 | New York Blood Center | Methods for preventing the transmission of or treating patients infected with herpesvirus |
| WO1999055326A1 (en) | 1998-04-30 | 1999-11-04 | Vit-Immune, L.C. | Method of treatment of glutathione deficient mammals |
| EP1094824B1 (en) * | 1998-06-10 | 2006-04-05 | Albert B. Crum | Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
| US6667063B2 (en) | 1998-06-10 | 2003-12-23 | Albert Crum | Nutritional or therapeutic supplement and method |
| US6203805B1 (en) | 1998-11-10 | 2001-03-20 | Color Access, Inc. | Topical compositions containing whey proteins |
| US6864242B2 (en) | 2001-03-05 | 2005-03-08 | Stephen P. Ernest | Enteral formulation |
| US6503506B1 (en) * | 2001-08-10 | 2003-01-07 | Millenium Biotechnologies, Inc. | Nutrient therapy for immuno-compromised patients |
| US20060057131A1 (en) * | 2001-12-20 | 2006-03-16 | Eric Simard | Malleable protein matrix and uses thereof |
| FR2840318B1 (fr) * | 2002-05-29 | 2004-12-03 | Quoc Kiet Pham | Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih |
| FR2889067B1 (fr) * | 2005-07-29 | 2011-11-11 | Cie Laitiere Europeenne | "utilisation d'une fraction proteique laitiere pour preparer une composition amincissante et/ou ameliorant la composition corporelle" |
| DE102006052504A1 (de) | 2006-11-06 | 2008-05-08 | Temper, Rupert | Verfahren zum Herstellen eines Mittels gegen eine Infektionskrankheit |
| US20080119386A1 (en) * | 2006-11-22 | 2008-05-22 | Carl Germano | Nutritional formula for athletes' recovery |
| AP2009004963A0 (en) * | 2007-02-06 | 2009-10-31 | Cymcorp Internat Inc | Novel non-toxic composition and method of using such for treating a degenerative or an immune systemrelated disease |
| US20100069288A1 (en) * | 2008-09-12 | 2010-03-18 | Wulf Droge | Use of cysteine-rich whey derived protein in patients receiving chemotherapy or radiotherapy to improve patient survival |
| JP2013079216A (ja) * | 2011-10-04 | 2013-05-02 | Snow Brand Milk Products Co Ltd | 感覚改善剤 |
| JP6234777B2 (ja) * | 2013-10-31 | 2017-11-22 | 株式会社日立製作所 | 光多値送信器および光トランスポンダ |
| DE102014001037A1 (de) * | 2014-01-25 | 2015-07-30 | Gea Tds Gmbh | Verfahren und Vorrichtung zur Reduzierung des Wachstums thermophiler Keime in Magermilch |
| US20190262401A1 (en) | 2016-09-23 | 2019-08-29 | Immunotec Inc. | Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders |
| CA2970699A1 (en) | 2017-06-14 | 2018-12-14 | Elizabeth E. Ignowski | Compositions for increasing resilience to traumatic brain injury |
| US11944649B2 (en) | 2017-07-31 | 2024-04-02 | Immunotec Inc. | Compositions and methods for treatment of autism spectrum disorder |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA858533A (en) * | 1970-12-15 | Lahav Eitan | Polypeptidic antibiotic substances derived from casein by fermentation | |
| FR2565985B1 (fr) * | 1984-06-19 | 1987-09-25 | Rhone Poulenc Sante | Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent |
| US4880626A (en) * | 1985-01-18 | 1989-11-14 | Mcmichael John | Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
| US4983387A (en) * | 1986-05-19 | 1991-01-08 | Viral Technologies Inc. | HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus |
| US5030449A (en) * | 1988-07-21 | 1991-07-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Synthetic vaccine against AIDS virus |
| EP0338229B1 (de) * | 1988-04-19 | 1993-06-16 | Biotest Pharma Gmbh | Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen |
| FI892006A (fi) * | 1988-04-29 | 1989-10-30 | Phil Gold | Lactalbumin saosom tillaeggsaemne i mat. |
| CA1338682C (en) * | 1988-12-23 | 1996-10-29 | Gustavo Bounous | Biologically active undenatured whey protein concentrate as food supplement |
| CA2007258A1 (en) * | 1989-01-11 | 1990-07-11 | Richard L. Jackson | Heparin fraction with anti-hiv activity |
| EP0385909B1 (en) * | 1989-03-03 | 1994-07-13 | MicroGeneSys, Inc. | A kit or composition for the prevention or treatment of HIV-1 infections |
| AU645016B2 (en) * | 1989-06-02 | 1994-01-06 | Johns Hopkins University School Of Medicine, The | Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| CA2022394A1 (en) * | 1989-08-07 | 1991-02-08 | Allen I. Oliff | Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| DK0790308T3 (da) * | 1989-12-22 | 2007-10-08 | Hoffmann La Roche | Cytoksisk lymfocytmodningsfaktor 35kD-underenhed samt monoklonale antistoffer rettet derimod |
| US5112373A (en) * | 1991-06-17 | 1992-05-12 | Hung Pham | Apparatus for controlling and eliminating vapor emissions at a manicure work station |
-
1992
- 1992-04-10 US US07/866,756 patent/US5456924A/en not_active Expired - Lifetime
-
1993
- 1993-02-23 CA CA002090186A patent/CA2090186C/en not_active Expired - Lifetime
- 1993-03-22 JP JP5517869A patent/JP2738592B2/ja not_active Expired - Lifetime
- 1993-03-22 NZ NZ251271A patent/NZ251271A/en unknown
- 1993-03-22 ES ES93907682T patent/ES2143503T3/es not_active Expired - Lifetime
- 1993-03-22 AU AU38812/93A patent/AU687731B2/en not_active Expired
- 1993-03-22 EP EP93907682A patent/EP0634934B1/en not_active Expired - Lifetime
- 1993-03-22 KR KR1019940703473A patent/KR100297959B1/ko not_active IP Right Cessation
- 1993-03-22 AT AT93907682T patent/ATE187335T1/de active
- 1993-03-22 DE DE69327236T patent/DE69327236T2/de not_active Expired - Lifetime
- 1993-03-22 DK DK93907682T patent/DK0634934T3/da active
- 1993-03-22 WO PCT/CA1993/000107 patent/WO1993020831A1/en active IP Right Grant
- 1993-03-22 CZ CZ942461A patent/CZ283386B6/cs not_active IP Right Cessation
- 1993-04-07 MX MX9302057A patent/MX9302057A/es unknown
- 1993-04-08 IL IL10533993A patent/IL105339A/en not_active IP Right Cessation
- 1993-04-08 ZA ZA932526A patent/ZA932526B/xx unknown
- 1993-04-09 TW TW082102661A patent/TW384223B/zh not_active IP Right Cessation
- 1993-04-09 CN CN93104081A patent/CN1070371C/zh not_active Expired - Lifetime
-
1994
- 1994-10-07 NO NO19943804A patent/NO317795B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2143503T3 (es) | 2000-05-16 |
| NO943804D0 (no) | 1994-10-07 |
| CZ246194A3 (en) | 1995-04-12 |
| AU687731B2 (en) | 1998-03-05 |
| WO1993020831A1 (en) | 1993-10-28 |
| US5456924A (en) | 1995-10-10 |
| NZ251271A (en) | 1998-05-27 |
| CN1070371C (zh) | 2001-09-05 |
| CA2090186C (en) | 1999-03-16 |
| JP2738592B2 (ja) | 1998-04-08 |
| EP0634934B1 (en) | 1999-12-08 |
| EP0634934A1 (en) | 1995-01-25 |
| JPH07504677A (ja) | 1995-05-25 |
| IL105339A (en) | 1998-07-15 |
| CN1083704A (zh) | 1994-03-16 |
| ATE187335T1 (de) | 1999-12-15 |
| NO317795B1 (no) | 2004-12-13 |
| DE69327236T2 (de) | 2000-03-30 |
| CZ283386B6 (cs) | 1998-04-15 |
| CA2090186A1 (en) | 1993-10-11 |
| KR950700752A (ko) | 1995-02-20 |
| MX9302057A (es) | 1994-07-29 |
| DK0634934T3 (da) | 2000-06-13 |
| NO943804L (no) | 1994-10-07 |
| IL105339A0 (en) | 1993-08-18 |
| KR100297959B1 (ko) | 2001-10-24 |
| AU3881293A (en) | 1993-11-18 |
| TW384223B (en) | 2000-03-11 |
| DE69327236D1 (de) | 2000-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA932526B (en) | Method of treatment of hiv-seropositive individuals with dietary whey proteins | |
| EP0339656A2 (en) | Undenatured whey protein concentrate | |
| AU1285592A (en) | Methods for increasing extracellular adenosine and for stabilizing mast cells | |
| PL338219A1 (en) | Therapeutic and dietary compositions containing necessary unsaturated fatty acids and biologically active disulphides | |
| AU3844297A (en) | Treatment of autoimmune diseases | |
| Miller et al. | Plasmodium falciparum: thiol status and growth in normal and glucose-6-phosphate dehydrogenase deficient human erythrocytes | |
| EP0176094A1 (en) | Parenteral alimentation solution | |
| Yamashita et al. | Response of superoxide anion production by guinea pig eosinophils to various soluble stimuli: comparison to neutrophils | |
| DE68924429D1 (de) | Diät zur besserem Ueberleben von Kranken mit Sepsis. | |
| CA2060560A1 (en) | Method for insuring adequate intracellular glutathione in tissue | |
| CA2010054A1 (en) | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin | |
| Stern et al. | Peptidase activity in leucocytes, erythrocytes and plasma of young adult and senile subjects | |
| AU1138288A (en) | Use of human blood coagulation factor xiii for the treatment of ulcerative colitis | |
| Gómez-Carrasco et al. | Scurvy in adolescence | |
| Hunaiti et al. | Effects of iron, zinc, calcium, and vitamins on the activity and contents of human placental copper/zinc and manganese superoxide dismutases | |
| 汪坤熔 et al. | Remission of Acute Myelofibrosis after Vitamin D_3 Treatment: A Case Report | |
| DE59611330D1 (de) | Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen | |
| IOKU | Methemoglobin formation from hemoglobin by nitrite ion in the erythrocytes of normal and acatalasemic mice; in vivo and in vitro study | |
| Toy et al. | Ascorbic acid, vitamin A, folic acid, and amino acids in blood of patients with hemophilia | |
| Peters et al. | Amino Acids and L-Asparaginase Activity in the Plasma of Owl Monkeys (Aotus trivirgatus) | |
| NZ243860A (en) | Increasing glutathione levels in human and animal organs using whey protein concentrate | |
| Ettinger | ALTERATION OF FOLATE AND ZINC STATUS WITH AGE. | |
| Wee et al. | Changes in blood cellular components, serum chemical values and serum enzyme activities in Korean native cattle infested with Fasciola hepatica | |
| Johnson et al. | Artificial gut bioassay system- Influence of ascorbic acid on the bio-availability of iron from hydroponic spinach using human Caco-2 cell line(Abstract only) | |
| TAKAMATSU et al. | The role of changes of erythrocyte membrane proteins on blood filtrability The effect of blood preservation |